Dr. med. Rosa Sonja Alesci
Publikationen
• Alesci RS, Goldmann G, Halimeh S, Holstein K, Königs C, Miesbach W, Pfrepper C, Olivieri M. Patient perspective on living with mild hemophilia in Germany: results from a nationwide survey. Front Med (Lausanne). 2024 Feb 5;11:1347024. doi: 10.3389/fmed.2024.1347024.
• Alesci RS, Hecking C, Weissmann MV. Identification of an Unmet Medical Need: Height of Depression, Hypersomnia, and Sleep Apnea Positively Correlate With the Level of Fatigue in Patients With Immune Thrombocytopenia. Cureus. 2023 Oct 13;15(10):e47003. doi: 10.7759/cureus.47003. PMID: 37965409;
• Alesci RS, Hecking C, Racké B, Janssen D, Dempfle CE. Utility of ACMG classification to support interpretation of molecular genetic test results in patients with factor VII deficiency. Front Med (Lausanne). 2023 Jul 14;10:1220813. doi: 10.3389/fmed.2023.1220813.
• Matzdorff A, Alesci SR, Gebhart J, Holzhauer S, Hütter-Krönke ML, Kühne T, Meyer O, Ostermann H, Pabinger I, Rummel M, Sachs UJ, Stauch T, et al [Expertenreport Immunthrombozytopenie – Aktuelle Diagnostik und Therapie]. Oncol Res Treat. 2023;46 Suppl 1:7-53. German. doi: 10.1159/000528819.
• Schmitt FCF, von der Forst M, Miesbach W, Casu S, Weigand MA, Alesci S. Mild Acquired Factor XIII Deficiency and Clinical Relevance at the ICU-A Retrospective Analysis. Clin Appl Thromb Hemost. 2021;27:10760296211024741.
• Endothelial Function in Patients With Von Willebrand Disease. Stephanie Noone, Ralf Schubert, Stephan Fichtlscherer, Thomas Hilberg, Sonja Alesci, Wolfgang MiesbachClin Appl Thromb Hemost. 2021 Jan-Dec; 27: 1076029620984546.
• Rare bleeding disorders are associated with depression and anxiety. Alesci SR, Schwan V, Miesbach W, Seifried E, Klinger D., Hamostaseologie. 2013;33 Suppl 1:S64-8.
• Platelet inhibition and bleeding complications in patients with haemophilia/von Willebrand’s disease and coronary artery disease., Alesci S, Krekeler S, Seifried E, Miesbach W., Haemophilia. 2012 Sep;18(5):e364-5.
• Patients with isolated prolonged in vitro bleeding time. Clinical symptoms., Alesci S, Stein M, Scholz K, Llugaliu B, Asmelash G, Miesbach W., Hamostaseologie. 2011 Nov;31 Suppl 1:S64-8.
• Successful treatment of an injury bleeding on a patient suffering from mild von Willebrand’s disease and predisposition to allergic diseases, with recombinant factor VIIA. Alesci S, Krekeler S, Miesbach W Haemophilia. 2011;17(3):545-6.
• First report on the effect of thrombin and factor Xa on cardiomyocytes in a three-dimensional cell culture model.
• Alesci S, Bartholomae P, Kaden JJ, Thieleke H, Süselbeck T, Wolpert C, Robitzki A, Reiniger-Mack A, Borggrefe M, Dempfle CE. Thromb Res. 2009 J; 124(3):375-6. doi: 10.1016/j.thromres.2008.11.013.
• Effect of freezing method and storage at -20 degrees C and -70 degrees C on prothrombin time, aPTT and plasma fibrinogen levels., Alesci S, Borggrefe M, Dempfle CE. Thromb Res. 2009 May;124(1):121-6.
• Do patients with haemophilia and von Willebrand disease with arterial hypertension have bleeding complications: a German single centre cohort.
• Alesci RS, Krekeler S, Seifried E, Miesbach W. Blood Coagul Fibrinolysis. 2012 Jun;23(4):320-3.
• Is gingival bleeding a symptom of patients with type 1 von Willebrand disease? A case-control study. Weickert L, Miesbach W, Alesci SR, Eickholz P, Nickles K. J Clin Periodontol. 2014 Aug;41(8):766-71
• Impact of the type of SERPINC1 mutation and subtype of antithrombin deficiency on the thrombotic phenotype in hereditary antithrombin deficiency., Luxembourg B, Pavlova A, Geisen C, Spannagl M, Bergmann F, Krause M, Alesci S, Seifried E, Lindhoff-Last E. Thromb Haemost. 2014; 111(2):249-57.
• No detection of the retrovirus xenotropic murine leukemia virus-related virus in individuals with hemophilia., Schüttrumpf J, Hourfar MK, Alesci S, Miesbach W, Seifried E, Schmidt M., Transfus Med Hemother. 2013 Feb;40(1):32-5.
• Treatment of haemophilia in the elderly., Miesbach W, Krekeler S, Alesci S., Hamostaseologie. 2009 Oct;29 Suppl 1:S29-31.
• Age-dependent increase of FVIII:C in mild haemophilia A., Miesbach W, Alesci S, Krekeler S, Seifried E., Haemophilia. 2009 Sep; 15(5):1022-6. doi: 10.1111/j.1365-2516.2009.02051
• Comorbidities and bleeding pattern in elderly haemophilia A patients., Miesbach W, Alesci S, Krekeler S, Seifried E., Haemophilia. 2009 Jul; 15(4):894-9. doi: 10.1111/j.1365-2516.2009.02030.
• Miesbach W, Krekeler S, Dück O, Llugaliu B, Asmelash G, Schüttrumpf J, Alesci SR, Grossmann R. Clinical assessment of efficacy and safety of DDAVP., Hamostaseologie. 2010 Nov;30 Suppl 1:S172-5.
• Association between phenotype and genotype in carriers of haemophilia A., Miesbach W, Alesci S, Geisen C, Oldenburg J. Haemophilia. 2010.
• Miesbach W, Schenk J, Alesci S, Lindhoff-Last E., Comparison of the fibrinogen Clauss assay and the fibrinogen PT derived method in patients with dysfibrinogenemia.Thromb Res. 2010; 126(6):428-33.
• Nickles K, Wohlfeil M, Alesci S, Miesbach W, Eickholz P., Comprehensive treatment of periodontitis in patients with von Willebrand disease. J Periodontol. 2010 Oct;81(10):1432-40.
• Dempfle CE, Argiriou S, Alesci S, Kucher K, Muller-Peltzer H, Rubsamen K, Heene DL. Fibrin formation and proteolysis during ancrod treatment. Evidence for des-A-profibrin formation and thrombin independent factor XIII activity., Ann N Y Acad Sci. 2001; 936:210-4.
• Dempfle CE, Alesci S, Kucher K, Muller-Peltzer H, Rubsamen K, Borggrefe M. Plasminogen activation without changes in tPA and PAI-1 in response to subcutaneous administration of ancrod.Thromb Res. 2001;104(6):433-8.